» Articles » PMID: 38466077

Machine Learning Models Reveal Distinct Disease Subgroups and Improve Diagnostic and Prognostic Accuracy for Individuals with Pathogenic SCN8A Gain-of-function Variants

Overview
Journal Biol Open
Specialty Biology
Date 2024 Mar 11
PMID 38466077
Authors
Affiliations
Soon will be listed here.
Abstract

Distinguishing clinical subgroups for patients suffering with diseases characterized by a wide phenotypic spectrum is essential for developing precision therapies. Patients with gain-of-function (GOF) variants in the SCN8A gene exhibit substantial clinical heterogeneity, viewed historically as a linear spectrum ranging from mild to severe. To test for hidden clinical subgroups, we applied two machine-learning algorithms to analyze a dataset of patient features collected by the International SCN8A Patient Registry. We used two research methodologies: a supervised approach that incorporated feature severity cutoffs based on clinical conventions, and an unsupervised approach employing an entirely data-driven strategy. Both approaches found statistical support for three distinct subgroups and were validated by correlation analyses using external variables. However, distinguishing features of the three subgroups within each approach were not concordant, suggesting a more complex phenotypic landscape. The unsupervised approach yielded strong support for a model involving three partially ordered subgroups rather than a linear spectrum. Application of these machine-learning approaches may lead to improved prognosis and clinical management of individuals with SCN8A GOF variants and provide insights into the underlying mechanisms of the disease.

Citing Articles

Machine Learning-Based Identification of High-Risk Patterns in Atrial Fibrillation Ablation Outcomes.

Oloko-Oba M, Liu Y, Wood K, Lloyd M, Ho J, Hertzberg V medRxiv. 2024; .

PMID: 39649597 PMC: 11623726. DOI: 10.1101/2024.11.27.24318097.

References
1.
Lee J, Rhee T, Hahn J, Hwang D, Park J, Park K . Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry. Int J Cardiol. 2017; 230:181-190. DOI: 10.1016/j.ijcard.2016.12.176. View

2.
Johannesen K, Gardella E, Ahring P, Moller R . De novo SCN3A missense variant associated with self-limiting generalized epilepsy with fever sensitivity. Eur J Med Genet. 2022; 65(10):104577. DOI: 10.1016/j.ejmg.2022.104577. View

3.
Taushanov Z, Verloo H, Wernli B, Di Giovanni S, von Gunten A, Pereira F . Transforming a Patient Registry Into a Customized Data Set for the Advanced Statistical Analysis of Health Risk Factors and for Medication-Related Hospitalization Research: Retrospective Hospital Patient Registry Study. JMIR Med Inform. 2021; 9(5):e24205. PMC: 8150425. DOI: 10.2196/24205. View

4.
Cutts A, Savoie H, Hammer M, Schreiber J, Grayson C, Luzon C . Clinical characteristics and treatment experience of individuals with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE): Findings from an online caregiver survey. Seizure. 2022; 97:50-57. DOI: 10.1016/j.seizure.2022.03.008. View

5.
Bosselmann C, Hedrich U, Lerche H, Pfeifer N . Predicting functional effects of ion channel variants using new phenotypic machine learning methods. PLoS Comput Biol. 2023; 19(3):e1010959. PMC: 10019634. DOI: 10.1371/journal.pcbi.1010959. View